What are the odds of developing opioid addiction after a standard surgical prescription?
Evidence quality 4.5/5
Eight-dimension review score against the quality rubric . Each dimension scored 1–5.
- D1 Source grounding
- 4/5
- D2 Source authority
- 5/5
- D3 Arithmetic
- 4/5
- D4 Uncertainty
- 4/5
- D5 Scope
- 5/5
- D6 Prose
- 5/5
- D7 Perception honesty
- 4/5
- D8 Caveat completeness
- 5/5
Lifetime probability · lifetime, US adult
1 in 114
0.9% lifetime chance
Most people underestimate this.
range 1 in 333 to 1 in 40
≈ As likely as
Perceived
Most surgical patients receive no explicit warning about addiction risk from opioid prescriptions before they leave the recovery room. The dominant cultural model of opioid addiction involves illicit drug use or long-term chronic pain management, not a standard post-operative pain prescription. When the topic does surface, patients typically anchor on the rare, dramatic case — the athlete who developed dependence after a sports injury — rather than on any population-level probability. Survey data on pre-surgical opioid addiction risk perception do not exist in any rigorous form, which is itself informative: it is a risk most patients have never been asked to estimate, and most clinicians have not routinely quantified.
Source: editorial intuition, not polled
Actual
~1.2% of opioid-naive surgical patients develop prolonged opioid use (3+ months post-surgery); 6.7% across all patients including those with prior opioid use
US adults, opioid-naive prior to surgery (JAMA Network Open 2020 meta-analysis of 33 studies, 1.9M patients)
Show derivation
The JAMA Network Open 2020 meta-analysis (Huang et al.) of 33 studies covering more than 1.9 million patients found a pooled incidence of prolonged opioid use after surgery of 6.7% (95% CI 4.5%-9.8%) across ALL patients. Critically, when restricted to opioid-naive patients specifically, the pooled rate dropped to 1.2% (95% CI 0.4%-3.9%). The much-cited Brummett et al. (JAMA Surgery, 2017) figure of 5.9%-6.5% defined "opioid-naive" as no opioid fills 12 months to 1 month before surgery — a looser criterion that may include patients with earlier opioid exposure. The 2020 meta-analysis provides the better estimate for truly opioid-naive patients, which is the relevant population for the question "what happens after a standard surgical prescription." Central estimate: 1.2% per surgical opioid exposure for opioid-naive patients. For lifetime normalization: a US adult has roughly 2-3 surgical procedures over their lifetime requiring opioid prescription (conservative estimate). Using 3 lifetime exposures and assuming independence: cumulative risk of at least one prolonged use episode = 1 - (1 - 0.012)^3 = 0.0356. Adjusting for the OUD conversion rate (~20-30% of persistent users develop OUD): 0.0356 x 0.25 = 0.0089. We use 0.0088 as the central estimate (~1 in 114). The SAMHSA 4.8M OUD prevalence / 260M US adults = 1.85% annual prevalence serves as a plausibility anchor (captures all pathways, not just surgical). Note: for patients with prior opioid exposure, the 6.7% pooled rate applies, with preoperative opioid use conferring 5.3-fold excess risk.
Caveats: The 1.2% persistent opioid use figure for opioid-naive patients (JAMA Network Op…
The 1.2% persistent opioid use figure for opioid-naive patients (JAMA Network Open 2020 meta-analysis) measures continued prescription filling beyond 3 months, which is a proxy for problematic use — not a direct diagnosis of opioid use disorder (OUD). Not all persistent users develop OUD; estimates of the OUD conversion rate range from 8-26% depending on the study and definition used. The widely cited 6% figure (Brummett et al., 2017; 6.7% in the meta-analysis) applies to all surgical patients including those with prior opioid exposure — preoperative opioid use confers a 5.3-fold excess risk. The risk is also dramatically elevated for patients with prior substance use disorders, mood disorders, anxiety disorders, or pre-existing chronic pain conditions. Risk is higher for longer initial prescriptions (>7 days) and higher morphine milligram equivalents. The 1.2% headline figure applies to truly opioid-naive adults receiving standard post-surgical prescriptions; for patients with any prior opioid history, the 6.7% all-patient rate is more applicable.
Risks at similar odds
Other risks with roughly the same likelihood — useful for calibration.
Benzo dependence
What are the odds of developing benzodiazepine dependence after a standard prescription?
Cat litter toxoplasmosis
What are the odds of acquiring a toxoplasma infection from cleaning a cat's litter box?
Recently viewed on this device
Stored locally — clear anytime.
Pick challenger
The 2020 JAMA Network Open meta-analysis of 33 studies covering more than 1.9 million patients found a pooled incidence of 6.7% for prolonged opioid use beyond three months across all surgical patients — but for opioid-naive patients specifically, the rate dropped to 1.2% (95% CI 0.4%-3.9%). That distinction matters enormously: the much-cited Brummett et al. (2017) figure of 5.9%-6.5% used a looser definition of “opioid-naive” (no fills in the prior 12 months to 1 month before surgery), while the meta-analysis restricted analysis showed that truly naive patients face a much lower per-exposure risk. Preoperative opioid use was the strongest risk factor, conferring a 5.3-fold excess risk. The non-operative control rate was only 0.4%, confirming that the surgical prescription itself is the mechanism. Translated to population scale: SAMHSA’s 2024 National Survey on Drug Use and Health found 4.8 million Americans had opioid use disorder in the past year — a figure that includes all pathways, but the prescription surgery route is one of the most systematically documented entry points.
The gap between perceived and actual risk here runs in an unusual direction: it is the underestimation that creates harm. Most patients going into elective procedures receive a post-operative opioid prescription the same way they receive discharge instructions for wound care — as a routine part of the package, without a quantified risk conversation. The clinical model that dominated prescribing for decades held that pain patients rarely become addicted; the empirical literature from the 2010s and 2020s has comprehensively revised that view. What makes the prescription pathway particularly insidious is that the exposure is clinically authorized, the initial use is legitimate, and the transition to problematic use happens on a timeline — weeks to months — that can feel indistinguishable from normal recovery variation until it does not.
Risk is not evenly distributed across the surgical population. Patients with prior substance use disorders face five to ten times higher rates of persistent opioid use post-surgery, and those with mood or anxiety disorders, chronic pain conditions, or tobacco use are also substantially elevated. Longer initial prescriptions — more than seven days — and higher daily doses independently predict persistent use regardless of surgical type. The 1.2% figure applies to opioid-naive patients; for those with any prior opioid history, the 6.7% all-patient rate is more applicable. For a 55-year-old with no prior substance history receiving a three-day supply after an uncomplicated knee arthroscopy, the risk is at the low end. For a 38-year-old with anxiety, a prior alcohol problem, and chronic back pain receiving a two-week supply after lumbar fusion, it is materially higher — potentially approaching or exceeding the 6.7% average.
Claim ledger
Every number below is what each source reported, with the verbatim quote we relied on and how we arrived at our figure. Click any link to verify directly.
-
[1] Brummett CM et al. — JAMA Surgery, 2017 — New Persistent Opioid Use After Minor and Major Surgical Procedures in US Adults
New Persistent Opioid Use After Minor and Major Surgical Procedures in US Adults- Statistic
5.9%-6.5% of opioid-naive surgical patients develop new persistent opioid use after surgery; rate is similar across minor and major procedures; 14x higher than the 0.4% rate in non-surgical controls.- Excerpt
“"The rates of new persistent opioid use were similar between the minor and major surgical groups (5.9%-6.5%). By comparison, the incidence in the nonoperative control cohort was only 0.4%." ”
- Source data from
- 2017-06-21
- Accessed
- 2026-04-24
- Calculation
- Brummett et al. found 5.9%-6.5% persistent opioid use among patients they classified as "opioid-naive" (no opioid fills 12 months to 1 month before surgery). However, the later JAMA Network Open 2020 meta-analysis found that when restricted to strictly opioid-naive patients, the rate drops to 1.2% (95% CI 0.4%-3.9%), suggesting that Brummett's looser "naive" definition included patients with earlier opioid exposure. The non-operative control rate of 0.4% confirms the surgical prescription as the mechanism. The Brummett 5.9%-6.5% figure applies to all surgical patients (including those with some prior opioid history) and should not be cited as the opioid-naive rate.
-
[2] JAMA Network Open, 2020 — Rate and Risk Factors Associated With Prolonged Opioid Use After Surgery: A Systematic Review and Meta-analysis
Rate and Risk Factors Associated With Prolonged Opioid Use After Surgery: A Systematic Review and Meta-analysis- Statistic
Pooled incidence of prolonged opioid use after surgery was 6.7% (95% CI 4.5%-9.8%) across all patients; 1.2% (95% CI 0.4%-3.9%) when restricted to opioid-naive patients; preoperative opioid use confers 5.3-fold excess risk.- Excerpt
“"In this systematic review and meta-analysis of 33 observational studies including more than 1.9 million patients, 7% of patients continued to fill opioid prescriptions more than 3 months after surgery. … Preoperative use of opioids, illicit cocaine use, and pain conditions before surgery had the strongest associations with prolonged opioid use after surgery." ”
- Source data from
- 2020-06-19
- Accessed
- 2026-04-24 · archived copy
- Calculation
- The pooled incidence of 6.7% (95% CI 4.5%-9.8%) from this meta-analysis of 33 studies involving more than 1.9 million patients covers all surgical patients regardless of prior opioid history. The critical finding for this entry is the restricted analysis: for opioid-naive patients specifically, the pooled rate is 1.2% (95% CI 0.4%-3.9%) — roughly one-fifth of the all-patient rate. This confirms that preoperative opioid use (OR 5.32) is the dominant driver of post-surgical persistent use. The 1.2% figure is used as the native rate because it best answers the question for a general adult facing a standard surgical prescription without prior opioid history.
-
[3] Substance Abuse and Mental Health Services Administration (SAMHSA) — Key Substance Use and Mental Health Indicators in the United States: Results from the 2024 National Survey on Drug Use and Health
Key Substance Use and Mental Health Indicators in the United States: Results from the 2024 National Survey on Drug Use and HealthSee all 3 Likelier entries citing this source →
- Statistic
4.8 million Americans aged 12 or older had opioid use disorder in the past year in 2024 (1.7% of that population).- Excerpt
“"In 2024, 4.8 million people aged 12 or older had a past year opioid use disorder, representing 1.7 percent of the population aged 12 or older." ”
- Source data from
- 2025-07-14
- Accessed
- 2026-04-24 · archived copy
- Calculation
- The SAMHSA 4.8M annual OUD prevalence provides a population-level cross-check. 4.8M / 260M US adults ≈ 1.85% current-year OUD prevalence. This figure captures all opioid sources (prescription and illicit), not just surgical pathways. It is used as a plausibility anchor for the normalized lifetime estimate rather than the primary calculation input.